Stock listing

A2PUCQ Stock Price, News, Filings & Events — Ascentage Pharma Group International

Selected listing: A2PUCQ · LSX · EUR · DE

A2PUCQ:LSX represents Ascentage Pharma Group International, a biopharmaceutical company focused on developing innovative therapies for cancer and age-related diseases. The company is actively engaged in clinical trials and research, aiming to advance its pipeline of drug candidates. Recent news highlights its ongoing efforts to expand partnerships and collaborations within the industry. Investors can find the latest filings and events related to Ascentage Pharma on this page, providing insights into its market activities and strategic direction.

A2PUCQ:LSXEURDEUpdated July 31, 2026
Ascentage Pharma Group International logo
Ticker
A2PUCQ:LSX
Asset type
Stock
Market cap
$1.62B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LSX
Currency
EUR

Ascentage Pharma Group International A2PUCQ:LSX stock context

A2PUCQ:LSX represents Ascentage Pharma Group International, a biopharmaceutical company focused on developing innovative therapies for cancer and age-related diseases. The company is actively engaged in clinical trials and research, aiming to advance its pipeline of drug candidates. Recent news highlights its ongoing efforts to expand partnerships and collaborations within the industry. Investors can find the latest filings and events related to Ascentage Pharma on this page, providing insights into its market activities and strategic direction.

Research Ascentage Pharma Group International

Alternate listings